Ceterach officinarum DC has been used in medicine as an antioxidant, anti-inflammatory, antifungal, and antibacterial agent. The aim of the present study was to investigate the hepatoprotective and hematoprotective effects of C. officinarum DC aqueous extract (CO) against streptozocin (STZ)-induced diabetes in mice. In this study, 60 mice were used. Diabetes was experimentally induced by intraperitoneal injection of STZ in 50 mice. Fasting blood glucose levels were assessed everyday by glucometer strips. Mice with plasma glucose level > 250 mg/dL were considered diabetic. After 3 days, they were divided randomly into six groups. Groups 1 and 2 served as non-diabetic and untreated diabetic controls, respectively. Group 3 received 50-mg/kg glibenclamide orally. Groups 4, 5, and 6 were given 50, 100, and 200 mg/kg, respectively, of CO for 20 days orally. At 20th day, the mice were dissected and blood and liver samples collected for hematological, biochemical, and histological parameter analysis. Different doses of CO (especially CO200) could significantly (p ≤ 0.05) decreased the raised levels of ALP, AST, ALT, cholesterol, LDL, WBC, and platelet and increased HDL, SOD, CAT, and RBC parameters as compared to the untreated group. The weight and volume of the hepatic structures were decreased significantly
Comparative Clinical Pathology – Springer Journals
Published: May 30, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud